1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Proliferative Diabetic Retinopathy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Anti-VEGF Agents 1.2.3 Corticosteroids 1.3 Market by Application 1.3.1 Global Proliferative Diabetic Retinopathy Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Proliferative Diabetic Retinopathy Market Perspective (2016-2027) 2.2 Proliferative Diabetic Retinopathy Growth Trends by Regions 2.2.1 Proliferative Diabetic Retinopathy Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Proliferative Diabetic Retinopathy Historic Market Share by Regions (2016-2021) 2.2.3 Proliferative Diabetic Retinopathy Forecasted Market Size by Regions (2022-2027) 2.3 Proliferative Diabetic Retinopathy Industry Dynamic 2.3.1 Proliferative Diabetic Retinopathy Market Trends 2.3.2 Proliferative Diabetic Retinopathy Market Drivers 2.3.3 Proliferative Diabetic Retinopathy Market Challenges 2.3.4 Proliferative Diabetic Retinopathy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Proliferative Diabetic Retinopathy Players by Revenue 3.1.1 Global Top Proliferative Diabetic Retinopathy Players by Revenue (2016-2021) 3.1.2 Global Proliferative Diabetic Retinopathy Revenue Market Share by Players (2016-2021) 3.2 Global Proliferative Diabetic Retinopathy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Proliferative Diabetic Retinopathy Revenue 3.4 Global Proliferative Diabetic Retinopathy Market Concentration Ratio 3.4.1 Global Proliferative Diabetic Retinopathy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Proliferative Diabetic Retinopathy Revenue in 2020 3.5 Proliferative Diabetic Retinopathy Key Players Head office and Area Served 3.6 Key Players Proliferative Diabetic Retinopathy Product Solution and Service 3.7 Date of Enter into Proliferative Diabetic Retinopathy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Proliferative Diabetic Retinopathy Breakdown Data by Type 4.1 Global Proliferative Diabetic Retinopathy Historic Market Size by Type (2016-2021) 4.2 Global Proliferative Diabetic Retinopathy Forecasted Market Size by Type (2022-2027) 5 Proliferative Diabetic Retinopathy Breakdown Data by Application 5.1 Global Proliferative Diabetic Retinopathy Historic Market Size by Application (2016-2021) 5.2 Global Proliferative Diabetic Retinopathy Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Proliferative Diabetic Retinopathy Market Size (2016-2027) 6.2 North America Proliferative Diabetic Retinopathy Market Size by Type 6.2.1 North America Proliferative Diabetic Retinopathy Market Size by Type (2016-2021) 6.2.2 North America Proliferative Diabetic Retinopathy Market Size by Type (2022-2027) 6.2.3 North America Proliferative Diabetic Retinopathy Market Size by Type (2016-2027) 6.3 North America Proliferative Diabetic Retinopathy Market Size by Application 6.3.1 North America Proliferative Diabetic Retinopathy Market Size by Application (2016-2021) 6.3.2 North America Proliferative Diabetic Retinopathy Market Size by Application (2022-2027) 6.3.3 North America Proliferative Diabetic Retinopathy Market Size by Application (2016-2027) 6.4 North America Proliferative Diabetic Retinopathy Market Size by Country 6.4.1 North America Proliferative Diabetic Retinopathy Market Size by Country (2016-2021) 6.4.2 North America Proliferative Diabetic Retinopathy Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Proliferative Diabetic Retinopathy Market Size (2016-2027) 7.2 Europe Proliferative Diabetic Retinopathy Market Size by Type 7.2.1 Europe Proliferative Diabetic Retinopathy Market Size by Type (2016-2021) 7.2.2 Europe Proliferative Diabetic Retinopathy Market Size by Type (2022-2027) 7.2.3 Europe Proliferative Diabetic Retinopathy Market Size by Type (2016-2027) 7.3 Europe Proliferative Diabetic Retinopathy Market Size by Application 7.3.1 Europe Proliferative Diabetic Retinopathy Market Size by Application (2016-2021) 7.3.2 Europe Proliferative Diabetic Retinopathy Market Size by Application (2022-2027) 7.3.3 Europe Proliferative Diabetic Retinopathy Market Size by Application (2016-2027) 7.4 Europe Proliferative Diabetic Retinopathy Market Size by Country 7.4.1 Europe Proliferative Diabetic Retinopathy Market Size by Country (2016-2021) 7.4.2 Europe Proliferative Diabetic Retinopathy Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Proliferative Diabetic Retinopathy Market Size (2016-2027) 8.2 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Type 8.2.1 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Type (2016-2027) 8.3 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Application 8.3.1 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Application (2016-2027) 8.4 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Region 8.4.1 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Proliferative Diabetic Retinopathy Market Size (2016-2027) 9.2 Latin America Proliferative Diabetic Retinopathy Market Size by Type 9.2.1 Latin America Proliferative Diabetic Retinopathy Market Size by Type (2016-2021) 9.2.2 Latin America Proliferative Diabetic Retinopathy Market Size by Type (2022-2027) 9.2.3 Latin America Proliferative Diabetic Retinopathy Market Size by Type (2016-2027) 9.3 Latin America Proliferative Diabetic Retinopathy Market Size by Application 9.3.1 Latin America Proliferative Diabetic Retinopathy Market Size by Application (2016-2021) 9.3.2 Latin America Proliferative Diabetic Retinopathy Market Size by Application (2022-2027) 9.3.3 Latin America Proliferative Diabetic Retinopathy Market Size by Application (2016-2027) 9.4 Latin America Proliferative Diabetic Retinopathy Market Size by Country 9.4.1 Latin America Proliferative Diabetic Retinopathy Market Size by Country (2016-2021) 9.4.2 Latin America Proliferative Diabetic Retinopathy Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Proliferative Diabetic Retinopathy Market Size (2016-2027) 10.2 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Type 10.2.1 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Type (2016-2027) 10.3 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Application 10.3.1 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Application (2016-2027) 10.4 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Country 10.4.1 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Intas Pharmaceuticals 11.1.1 Intas Pharmaceuticals Company Details 11.1.2 Intas Pharmaceuticals Business Overview 11.1.3 Intas Pharmaceuticals Proliferative Diabetic Retinopathy Introduction 11.1.4 Intas Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) 11.1.5 Intas Pharmaceuticals Recent Development 11.2 Santen Pharmaceutical 11.2.1 Santen Pharmaceutical Company Details 11.2.2 Santen Pharmaceutical Business Overview 11.2.3 Santen Pharmaceutical Proliferative Diabetic Retinopathy Introduction 11.2.4 Santen Pharmaceutical Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) 11.2.5 Santen Pharmaceutical Recent Development 11.3 Bausch Health 11.3.1 Bausch Health Company Details 11.3.2 Bausch Health Business Overview 11.3.3 Bausch Health Proliferative Diabetic Retinopathy Introduction 11.3.4 Bausch Health Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) 11.3.5 Bausch Health Recent Development 11.4 Allergan Plc 11.4.1 Allergan Plc Company Details 11.4.2 Allergan Plc Business Overview 11.4.3 Allergan Plc Proliferative Diabetic Retinopathy Introduction 11.4.4 Allergan Plc Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) 11.4.5 Allergan Plc Recent Development 11.5 Regeneron Pharmaceuticals 11.5.1 Regeneron Pharmaceuticals Company Details 11.5.2 Regeneron Pharmaceuticals Business Overview 11.5.3 Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Introduction 11.5.4 Regeneron Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) 11.5.5 Regeneron Pharmaceuticals Recent Development 11.6 Merck KGaA 11.6.1 Merck KGaA Company Details 11.6.2 Merck KGaA Business Overview 11.6.3 Merck KGaA Proliferative Diabetic Retinopathy Introduction 11.6.4 Merck KGaA Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) 11.6.5 Merck KGaA Recent Development 11.7 Cipla 11.7.1 Cipla Company Details 11.7.2 Cipla Business Overview 11.7.3 Cipla Proliferative Diabetic Retinopathy Introduction 11.7.4 Cipla Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) 11.7.5 Cipla Recent Development 11.8 Genentech, Inc. (Roche Holdings) 11.8.1 Genentech, Inc. (Roche Holdings) Company Details 11.8.2 Genentech, Inc. (Roche Holdings) Business Overview 11.8.3 Genentech, Inc. (Roche Holdings) Proliferative Diabetic Retinopathy Introduction 11.8.4 Genentech, Inc. (Roche Holdings) Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) 11.8.5 Genentech, Inc. (Roche Holdings) Recent Development 11.9 Novartis 11.9.1 Novartis Company Details 11.9.2 Novartis Business Overview 11.9.3 Novartis Proliferative Diabetic Retinopathy Introduction 11.9.4 Novartis Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) 11.9.5 Novartis Recent Development 11.10 Pfizer 11.10.1 Pfizer Company Details 11.10.2 Pfizer Business Overview 11.10.3 Pfizer Proliferative Diabetic Retinopathy Introduction 11.10.4 Pfizer Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) 11.10.5 Pfizer Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Proliferative Diabetic Retinopathy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Anti-VEGF Agents Table 3. Key Players of Corticosteroids Table 4. Global Proliferative Diabetic Retinopathy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Proliferative Diabetic Retinopathy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Proliferative Diabetic Retinopathy Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Proliferative Diabetic Retinopathy Market Share by Regions (2016-2021) Table 8. Global Proliferative Diabetic Retinopathy Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Proliferative Diabetic Retinopathy Market Share by Regions (2022-2027) Table 10. Proliferative Diabetic Retinopathy Market Trends Table 11. Proliferative Diabetic Retinopathy Market Drivers Table 12. Proliferative Diabetic Retinopathy Market Challenges Table 13. Proliferative Diabetic Retinopathy Market Restraints Table 14. Global Proliferative Diabetic Retinopathy Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Proliferative Diabetic Retinopathy Market Share by Players (2016-2021) Table 16. Global Top Proliferative Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Proliferative Diabetic Retinopathy as of 2020) Table 17. Ranking of Global Top Proliferative Diabetic Retinopathy Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Proliferative Diabetic Retinopathy Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Proliferative Diabetic Retinopathy Product Solution and Service Table 21. Date of Enter into Proliferative Diabetic Retinopathy Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Proliferative Diabetic Retinopathy Market Size by Type (2016-2021) (US$ Million) Table 24. Global Proliferative Diabetic Retinopathy Revenue Market Share by Type (2016-2021) Table 25. Global Proliferative Diabetic Retinopathy Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Proliferative Diabetic Retinopathy Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Proliferative Diabetic Retinopathy Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Proliferative Diabetic Retinopathy Revenue Market Share by Application (2016-2021) Table 29. Global Proliferative Diabetic Retinopathy Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Proliferative Diabetic Retinopathy Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Proliferative Diabetic Retinopathy Market Size by Type (2016-2021) (US$ Million) Table 32. North America Proliferative Diabetic Retinopathy Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Proliferative Diabetic Retinopathy Market Size by Application (2016-2021) (US$ Million) Table 34. North America Proliferative Diabetic Retinopathy Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Proliferative Diabetic Retinopathy Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Proliferative Diabetic Retinopathy Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Proliferative Diabetic Retinopathy Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Proliferative Diabetic Retinopathy Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Proliferative Diabetic Retinopathy Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Proliferative Diabetic Retinopathy Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Proliferative Diabetic Retinopathy Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Proliferative Diabetic Retinopathy Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Proliferative Diabetic Retinopathy Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Proliferative Diabetic Retinopathy Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Proliferative Diabetic Retinopathy Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Proliferative Diabetic Retinopathy Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Proliferative Diabetic Retinopathy Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Proliferative Diabetic Retinopathy Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Country (2022-2027) & (US$ Million) Table 61. Intas Pharmaceuticals Company Details Table 62. Intas Pharmaceuticals Business Overview Table 63. Intas Pharmaceuticals Proliferative Diabetic Retinopathy Product Table 64. Intas Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million) Table 65. Intas Pharmaceuticals Recent Development Table 66. Santen Pharmaceutical Company Details Table 67. Santen Pharmaceutical Business Overview Table 68. Santen Pharmaceutical Proliferative Diabetic Retinopathy Product Table 69. Santen Pharmaceutical Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million) Table 70. Santen Pharmaceutical Recent Development Table 71. Bausch Health Company Details Table 72. Bausch Health Business Overview Table 73. Bausch Health Proliferative Diabetic Retinopathy Product Table 74. Bausch Health Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million) Table 75. Bausch Health Recent Development Table 76. Allergan Plc Company Details Table 77. Allergan Plc Business Overview Table 78. Allergan Plc Proliferative Diabetic Retinopathy Product Table 79. Allergan Plc Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million) Table 80. Allergan Plc Recent Development Table 81. Regeneron Pharmaceuticals Company Details Table 82. Regeneron Pharmaceuticals Business Overview Table 83. Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Product Table 84. Regeneron Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million) Table 85. Regeneron Pharmaceuticals Recent Development Table 86. Merck KGaA Company Details Table 87. Merck KGaA Business Overview Table 88. Merck KGaA Proliferative Diabetic Retinopathy Product Table 89. Merck KGaA Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million) Table 90. Merck KGaA Recent Development Table 91. Cipla Company Details Table 92. Cipla Business Overview Table 93. Cipla Proliferative Diabetic Retinopathy Product Table 94. Cipla Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million) Table 95. Cipla Recent Development Table 96. Genentech, Inc. (Roche Holdings) Company Details Table 97. Genentech, Inc. (Roche Holdings) Business Overview Table 98. Genentech, Inc. (Roche Holdings) Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million) Table 99. Genentech, Inc. (Roche Holdings) Recent Development Table 100. Novartis Company Details Table 101. Novartis Business Overview Table 102. Novartis Proliferative Diabetic Retinopathy Product Table 103. Novartis Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million) Table 104. Novartis Recent Development Table 105. Pfizer Company Details Table 106. Pfizer Business Overview Table 107. Pfizer Proliferative Diabetic Retinopathy Product Table 108. Pfizer Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million) Table 109. Pfizer Recent Development Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Global Proliferative Diabetic Retinopathy Market Share by Type: 2020 VS 2027 Figure 2. Anti-VEGF Agents Features Figure 3. Corticosteroids Features Figure 4. Global Proliferative Diabetic Retinopathy Market Share by Application: 2020 VS 2027 Figure 5. Hospitals Case Studies Figure 6. Clinics Case Studies Figure 7. Others Case Studies Figure 8. Proliferative Diabetic Retinopathy Report Years Considered Figure 9. Global Proliferative Diabetic Retinopathy Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Proliferative Diabetic Retinopathy Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Proliferative Diabetic Retinopathy Market Share by Regions: 2020 VS 2027 Figure 12. Global Proliferative Diabetic Retinopathy Market Share by Regions (2022-2027) Figure 13. Global Proliferative Diabetic Retinopathy Market Share by Players in 2020 Figure 14. Global Top Proliferative Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Proliferative Diabetic Retinopathy as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Proliferative Diabetic Retinopathy Revenue in 2020 Figure 16. Global Proliferative Diabetic Retinopathy Revenue Market Share by Type (2016-2021) Figure 17. Global Proliferative Diabetic Retinopathy Revenue Market Share by Type (2022-2027) Figure 18. North America Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Proliferative Diabetic Retinopathy Market Share by Type (2016-2027) Figure 20. North America Proliferative Diabetic Retinopathy Market Share by Application (2016-2027) Figure 21. North America Proliferative Diabetic Retinopathy Market Share by Country (2016-2027) Figure 22. United States Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Proliferative Diabetic Retinopathy Market Share by Type (2016-2027) Figure 26. Europe Proliferative Diabetic Retinopathy Market Share by Application (2016-2027) Figure 27. Europe Proliferative Diabetic Retinopathy Market Share by Country (2016-2027) Figure 28. Germany Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Proliferative Diabetic Retinopathy Market Share by Type (2016-2027) Figure 36. Asia-Pacific Proliferative Diabetic Retinopathy Market Share by Application (2016-2027) Figure 37. Asia-Pacific Proliferative Diabetic Retinopathy Market Share by Region (2016-2027) Figure 38. China Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Proliferative Diabetic Retinopathy Market Share by Type (2016-2027) Figure 46. Latin America Proliferative Diabetic Retinopathy Market Share by Application (2016-2027) Figure 47. Latin America Proliferative Diabetic Retinopathy Market Share by Country (2016-2027) Figure 48. Mexico Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Proliferative Diabetic Retinopathy Market Share by Type (2016-2027) Figure 52. Middle East & Africa Proliferative Diabetic Retinopathy Market Share by Application (2016-2027) Figure 53. Middle East & Africa Proliferative Diabetic Retinopathy Market Share by Country (2016-2027) Figure 54. Turkey Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Intas Pharmaceuticals Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021) Figure 58. Santen Pharmaceutical Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021) Figure 59. Bausch Health Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021) Figure 60. Allergan Plc Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021) Figure 61. Regeneron Pharmaceuticals Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021) Figure 62. Merck KGaA Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021) Figure 63. Cipla Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021) Figure 64. Genentech, Inc. (Roche Holdings) Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021) Figure 65. Novartis Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021) Figure 66. Pfizer Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

Intas Pharmaceuticals Santen Pharmaceutical Bausch Health Allergan Plc Regeneron Pharmaceuticals Merck KGaA Cipla Genentech, Inc. (Roche Holdings) Novartis Pfizer